An experimental drug designed to lower a dangerous form of cholesterol showed no measurable impact on heart attacks or stroke in a clinical trial. Doctors had expected the medicine to save patients’ lives by lowering a common heart-attack risk factor.
Reporting from 2 identified publishers across this event arc.
These publishers contributed reporting to the broader event history. Not every source addresses the specific development described above.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Page 13 of 21783
Same format. Every time.
Continue reading — sign in or create a free account with
